These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 740584)

  • 21. Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding.
    Yildirim G; Tugrul S; Uslu H; Pekin O; Eren S
    Arch Gynecol Obstet; 2006 Feb; 273(5):268-73. PubMed ID: 16315025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endometrial thickness assessed by transvaginal ultrasound insufficiently predicts occurrence of hyperplasia during unopposed oestrogen use.
    Meuwissen JH; Oddens BJ; Klinkhamer PJ
    Maturitas; 1996 May; 24(1-2):21-30. PubMed ID: 8794430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endometrial pattern in patients with primary hypoestrogenic amenorrhea receiving estrogen replacement therapy.
    Van Campenhout J; Choquette P; Vauclair R
    Obstet Gynecol; 1980 Sep; 56(3):349-55. PubMed ID: 7422173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group.
    Archer DF; Pickar JH; Bottiglioni F
    Obstet Gynecol; 1994 May; 83(5 Pt 1):686-92. PubMed ID: 8164926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of progestogens on serum lipids in the post-menopause.
    Maddock J
    Postgrad Med J; 1978; 54 Suppl 2():38-41. PubMed ID: 740579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of a transdermal continuous combined and an interrupted progestogen HRT.
    Cameron ST; Glasier AF; Gebbie A; Dewart H; Baird DT
    Maturitas; 2006 Jan; 53(1):19-26. PubMed ID: 16325020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protecting the endometrium. Opposing the hyperplasia/malignancy potential of ERT.
    Gibbons WE; Thorneycroft IH
    J Reprod Med; 1999 Feb; 44(2 Suppl):203-8. PubMed ID: 11392033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [HRT in post-menopausal women: endometrial histology and bleeding patterns].
    Lo Dico G; Alongi G; Spinelli MP; Cannariato P; Lucido AM
    Minerva Ginecol; 2002 Aug; 54(4):361-6. PubMed ID: 12114870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The treatment of women with climacteric symptoms with emphasis on perimenopausal hormone therapy].
    Bogchelman DH; Lappöhn RE; Janssens J
    Ned Tijdschr Geneeskd; 1979 Jun; 123(25):1072-5. PubMed ID: 223071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progestogens versus oestrogens and progestogens for irregular uterine bleeding associated with anovulation.
    Hickey M; Higham J; Fraser IS
    Cochrane Database Syst Rev; 2000; (2):CD001895. PubMed ID: 10796833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The risk of endometrial carcinoma from oestrogen therapy of the menopause.
    Klopper A
    Acta Endocrinol Suppl (Copenh); 1980; 233():29-35. PubMed ID: 6773285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical effects of 17 beta-estradiol and norethisterone acetate in postmenopausal Thai women.
    Limpaphayom KK; Bunyavejchevin S
    J Med Assoc Thai; 2000 Apr; 83(4):407-16. PubMed ID: 10808701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormonal replacement regimens and bleeding.
    Dören M
    Maturitas; 2000 Jan; 34 Suppl 1():S17-23. PubMed ID: 10759060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progestogen deficiency and endometrial cancer risk.
    Schindler AE
    Maturitas; 2009 Apr; 62(4):334-7. PubMed ID: 19231117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous transdermal oestrogen and interrupted progestogen as a novel bleed-free regimen of hormone replacement therapy for postmenopausal women.
    Cameron ST; Critchley HO; Glasier AF; Williams AR; Baird DT
    Br J Obstet Gynaecol; 1997 Oct; 104(10):1184-90. PubMed ID: 9332998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endometrial pathology and estrogens.
    Rosenwaks Z; Wentz AC; Jones GS; Urban MD; Lee PA; Migeon CJ; Parmley TH; Woodruff JD
    Obstet Gynecol; 1979 Apr; 53(4):403-10. PubMed ID: 220573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention and treatment of endometrial disease in climacteric women receiving oestrogen therapy.
    Thom MH; White PJ; Williams RM; Sturdee DW; Paterson ME; Wade-Evans T; Studd JW
    Lancet; 1979 Sep; 2(8140):455-7. PubMed ID: 89511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of oestrogens and progestogens on the postmenopausal endometrium.
    Whitehead MI
    Maturitas; 1978 Sep; 1(2):87-98. PubMed ID: 755961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Oestrogens during the menopause and the risk of endometrial carcinoma (author's transl)].
    Lachnit-Fixson U
    Wien Klin Wochenschr; 1979 Feb; 91(4):111-8. PubMed ID: 218369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of endometrial abnormalities.
    Whitehead MI
    Acta Obstet Gynecol Scand Suppl; 1986; 134():81-91. PubMed ID: 3028029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.